H G Drexler
About
In The Last Decade
H G Drexler
26 papers receiving 780 citations
Peers
Comparison fields: 5 of 76
- Hematology 324
- Molecular Biology 318
- Immunology 216
- Genetics 157
- Oncology 153
Countries citing papers authored by H G Drexler
This map shows the geographic impact of H G Drexler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H G Drexler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H G Drexler more than expected).
Fields of papers citing papers by H G Drexler
This network shows the impact of papers produced by H G Drexler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H G Drexler. The network helps show where H G Drexler may publish in the future.
Co-authorship network of co-authors of H G Drexler
This figure shows the co-authorship network connecting the top 25 collaborators of H G Drexler. A scholar is included among the top collaborators of H G Drexler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H G Drexler. H G Drexler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 3 | |
| 3 | 60 | |
| 4 | 122 | |
| 5 | Myeloperoxidase positive acute lymphoblastic leukemia cell lines, NALM-30, NALM-31 and NALM-32, carrying Philadelphia chromosome with biphenotypic characteristics. | 1 |
| 6 | Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines. | 2 |
| 7 | Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. | 39 |
| 8 | The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. | 22 |
| 9 | Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines. | 37 |
| 10 | Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. | 51 |
| 11 | Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril). | 29 |
| 12 | Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. | 53 |
| 13 | Expression of the monocyte-specific esterase gene in leukemia-lymphoma cell lines. | 14 |
| 14 | 21 | |
| 15 | Hodgkin's disease derived cell lines: a review. | 27 |
| 16 | Elimination of mycoplasma from infected leukemia cell lines. | 15 |
| 17 | 5 | |
| 18 | 6 | |
| 19 | Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines. | 25 |
| 20 | Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.